about
Signaling pathways in the development of infantile hemangiomaEvaluation of intra-lesional corticosteroids in the treatment of peri-ocular haemangioma of infancy: still an alternative besides propranolol.Clinical efficacy of propranolol in the treatment of hemangioma and changes in serum VEGF, bFGF and MMP-9Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysisHemangiomas revisited: the useful, the unusual and the new. Part 1: overview and clinical and imaging characteristics.Skin tumors in childhoodPediatric dermatohistopathology--histopathology of skin diseases in newborns and infants.Transcriptional activation of Hedgehog pathway components in aggressive haemangioma.Fell-Muir Lecture: Regulatory mechanisms of skeletal and connective tissue development and homeostasis - lessons from studies of human disorders.Infantile Periocular Hemangioma.Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanismsTranslational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor.Neuropilin-2 and vascular endothelial growth factor receptor-3 are up-regulated in human vascular malformations.Combined oral propranolol with intralesional injection of triamcinolone acetonide in treatment of infantile periocular hemangiomas.M1 Macrophage-Induced Endothelial-to-Mesenchymal Transition Promotes Infantile Hemangioma Regression.Color Doppler Ultrasound Follow-Up of Infantile Hemangiomas and Peripheral Vascularity in Patients Treated with Propranolol.Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting.
P2860
Q26996608-75869166-D48A-4C16-922C-EDA897E13EB5Q35851345-170B0C23-C27C-4525-80BE-AF391D1F9E22Q35942857-1B27776A-A2E9-42A4-9244-2BE8F2BCF3B6Q36409111-5C9D2A18-F652-4810-B1F0-AE90993E5861Q37877159-3492948B-C84A-46E3-8D3D-D7B19F95BDCDQ37886715-10CD1F9F-1A5C-4D74-81A4-4275745C29D4Q38505061-8DC3A960-BF20-4084-8D19-6B91439BF470Q38859269-9BD358CA-2A0E-4541-B720-95BC6856EB55Q38942842-262FD722-6BD4-4858-AEF7-D9E131A83916Q39327604-CB7B7D1B-5347-4458-AF1F-0355A7BE5C70Q42111602-679DB534-D4FC-4D53-A1FB-4548B80A35A3Q43276342-DD612FC2-C253-456D-9270-AE7EA171E425Q45427181-39E715E9-3797-4520-B1A3-CEF9DA1A3D93Q47101929-6E00B64F-B4B6-4BCC-899A-3FB8CA96D2B4Q51826468-7E484484-D9E7-4BB4-9435-905ACEFF1A83Q53519551-C2172910-E3BA-47BA-837C-CE8FED5102B2Q53693166-4DD8B8D0-D2DF-4500-A8B9-6C808974A442
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Signaling mechanisms in infantile hemangioma
@ast
Signaling mechanisms in infantile hemangioma
@en
type
label
Signaling mechanisms in infantile hemangioma
@ast
Signaling mechanisms in infantile hemangioma
@en
prefLabel
Signaling mechanisms in infantile hemangioma
@ast
Signaling mechanisms in infantile hemangioma
@en
P2860
P1476
Signaling mechanisms in infantile hemangioma
@en
P2093
Bjorn R Olsen
Eileen Boye
P2860
P304
P356
10.1097/MOH.0B013E32832A07FF
P577
2009-05-01T00:00:00Z